Icon Cancer Centre Kurralta Park

Kurralta Park 5037

5 studies enrolling now · 7 studies all time

What they study most

Advanced Solid Tumor, Bladder Cancer, Carcinoma, Non-Small-Cell Lung, Cervical Cancer, Chronic Lymphocytic Leukemia, Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Metastatic Castration-resistant Prostate Neoplasms, Metastatic Castration-sensitive Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer, Metastatic Solid Tumor, Non-small Cell Lung Cancer

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer — Recruiting now
• Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
• A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Recruiting now
• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) — Running, not enrolling
• A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors — Running, not enrolling